Skip to main content

Advertisement

Log in

Cerebrovascular Manifestations of Pheochromocytoma and the Implications of a Missed Diagnosis

  • Practical Pearl
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background and Purpose

Cerebrovascular complications are a rare manifestation of pheochromocytoma. We report a case of pheochromocytoma presenting initially with reversible posterior leukoencephalopathy and subsequently a cerebral infarction.

Summary of Case

A patient with a prior history of episodic hypertension and reversible posterior leukoencephalopathy presented with headache, palpitations, and weakness of the right leg. A magnetic resonance angiogram revealed narrowing of the basilar and right middle cerebral artery. She was diagnosed as having presumed vasculitis and underwent a conventional cerebral angiogram during which she developed a hypertensive crisis and worsening neurological deficit. Further investigations revealed the presence of a pheochromocytoma, which was subsequently resected.

Conclusions

It is important to be cognizant of the possibility of pheochromocytoma in patients presenting with hypertension and cerebrovascular manifestations, as commonly used investigations (e.g. catheter angiography) and treatment modalities (e.g. β-blockers to treat hypertension, corticosteroids to treat suspected vasculitis, etc.) can lead to life threatening complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091–101.

    Article  PubMed  Google Scholar 

  2. Razavi M, Bendixen B, Maley JE, Zargarian M, Razavi B, Adams HP. CNS pseudovasculitis in a patient with pheochromocytoma. Neurology. 1999;52:1088–90.

    PubMed  CAS  Google Scholar 

  3. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. CPEP study group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992–1005.

    Article  PubMed  CAS  Google Scholar 

  4. Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006;354:980–2.

    Article  PubMed  CAS  Google Scholar 

  5. Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM, Pacak K. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drugs. 2007;30:1031–62.

    CAS  Google Scholar 

  6. Raisanen J, Shapiro B, Glazer GM, Desai S, Sisson JC. Plasma catecholamines in pheochromocytoma: effect of urographic contrast media. Am J Roentgenol. 1984;143:43–6.

    CAS  Google Scholar 

Download references

Acknowledgments

Conflicts of interest:

Tamara Majic: None. Venkatesh Aiyagari: Consultancy for Boehringer-Ingelheim.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Venkatesh Aiyagari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Majic, T., Aiyagari, V. Cerebrovascular Manifestations of Pheochromocytoma and the Implications of a Missed Diagnosis. Neurocrit Care 9, 378–381 (2008). https://doi.org/10.1007/s12028-008-9105-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-008-9105-8

Keywords

Navigation